Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists

Vivek Pai,Prakash Muthusami,Birgit Ertl-Wagner,Manohar M Shroff,Carmen Parra-Fariñas,Kanchan Sainani,Stephanie Kletke,Marie-Anne Brundler,Ashwin Mallipatna,Manohar M. Shroff
DOI: https://doi.org/10.1148/rg.230125
2024-04-01
Radiographics
Abstract:Retinoblastoma is the most common cause of all intraocular pediatric malignancies. It is caused by the loss of <i>RB1</i> tumor suppressor gene function, although some tumors occur due to <i>MYCN</i> oncogene amplification with normal <i>RB1</i> genes. Nearly half of all retinoblastomas occur due to a hereditary germline <i>RB1</i> pathogenic variant, most of which manifest with bilateral tumors. This germline <i>RB1</i> mutation also predisposes to intracranial midline embryonal tumors. Accurate staging of retinoblastoma is crucial in providing optimal vision-, eye-, and life-saving treatment. The <i>AJCC Cancer Staging Manual</i> has undergone significant changes, resulting in a universally accepted system with a multidisciplinary approach for managing retinoblastoma. The authors discuss the role of MRI and other diagnostic imaging techniques in the pretreatment assessment and staging of retinoblastoma. A thorough overview of the prevailing imaging standards and evidence-based perspectives on the benefits and drawbacks of these techniques is provided. Published under a CC BY 4.0 license. Test Your Knowledge questions for this article are available in the supplemental material.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?